The Nutshell

» cell & molecular biology, NIH and disease/medicine

Daily News Roundup

Most Recent

image: Facebook CEO’s Donation a Boon to Basic Science

Facebook CEO’s Donation a Boon to Basic Science

By | September 25, 2016

But can $3 billion dollars meet the lofty goals of the Chan Zuckerberg Initiative?

1 Comment

The National Institutes of Health is hosting a two-day conference on how the virus affects infants and children. The take-home message so far: microcephaly is but one of many potential problems for Zika-exposed fetuses.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

image: Viral Protein Boosts Muscle Mass in Male Mice

Viral Protein Boosts Muscle Mass in Male Mice

By | September 14, 2016

An endogenous retrovirus that supports placenta formation in females also helps male mice build muscle, according to a study.

0 Comments

image: Polio Reemerges in Nigeria

Polio Reemerges in Nigeria

By | August 15, 2016

Prior to last week’s announcement of newly confirmed cases, the country had been polio-free for two years.

1 Comment

image: NIH Reveals Plan to Fund Human-Animal Chimeras

NIH Reveals Plan to Fund Human-Animal Chimeras

By | August 4, 2016

The public gets to weigh in before the US government lifts its ban on such research.

0 Comments

image: NIMH Names New Director

NIMH Names New Director

By | August 3, 2016

Joshua Gordon of Columbia University Medical Center will lead the National Institute of Mental Health.

0 Comments

image: Additional #IceBucketChallenge Payoffs

Additional #IceBucketChallenge Payoffs

By | July 28, 2016

Researchers identify a new ALS-associated gene thanks to funds generated by the social media challenge that went viral in summer 2014.

0 Comments

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

Popular Now

  1. Next Generation: Mobile Microscope Detects DNA Sequences
  2. Scientists Activate Predatory Instinct in Mice
  3. Lipids Take the Lead in Metastasis
  4. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
RayBiotech